Reuters: Myriad Genetics to stop developing Alzheimer's drug

[NaDiNe]

Myriad Genetics to stop developing Alzheimer's drug
      

(Reuters) - Myriad Genetics Inc said it will stop developing its drug for Alzheimer's disease after a late-stage trial of the drug, Flurizan, failed to meet primary goals.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login